A computational biologist weighs in on Omicron, the future of vaccines, and the CDC’s variant forecast
At a time when the U.S. needed Covid-19 dialogue between scientists, Francis Collins moved to shut it down
The tragedy of Johnson & Johnson’s Covid vaccine
How medicine erased Black women from a ‘white man’s disease’
An Omicron oddity: The number of cases doesn’t predict the number of deaths
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry
2021 Update: Ranking biotech’s top venture capital firms
Good bacteria: The microbiome, its vast therapeutic potential, and the challenges ahead
